Literatur
- 1
Bartelt D C, Shapanka R, Greene L J.
The
primary structure of the human pancreatic secretory trypsin inhibitor.
Amino acid sequence of the reduced S-aminoethylated protein.
Arch
Biochem Biophys.
1977;
179
189-199
- 2
Chen J M, Raguénès O, Férec C, Deprez P H, Verellen-Dumoulin C, Andriulli A.
The A16V signal peptide
cleavage site mutation in the cationic trypsinogen gene and chronic
pancreatitis (letter).
Gastroenterology.
1999;
117
1508-1509
- 3
Chen J M, Mercier B, Audrezet M P, Raguenes O, Quere I, Ferec C.
Mutations of the pancreatic
secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis.
Gastroenterology.
2001;
120
1061-1063
- 4
Chiari H.
Über
Selbstverdauung des menschlichen Pankreas.
Zeitschrift
für Heilkunde.
1896;
17
69-96
- 5
Choi J Y, Muallem D, Kiselyov K, Lee M G, Thomas P J, Muallem S.
Aberrant CFTR-dependent
HCO3-transport in mutations associated with cystic fibrosis.
Nature.
2001;
410
94-97
- 6
Cohn J A, Friedman K J, Noone P G, Knowles M R, Silverman L M, Jowell P S.
Relation between
mutations of the cystic fibrosis gene and idiopathic pancreatitis.
New
Engl J Med.
1998;
339
653-658
- 7
Colomb E, Figarella C.
Comparative
studies on the mechanism of activation of the two human trypsinogens.
Biochem
Biophys Acta.
1979;
571
343-351
- 8
Comfort M W, Steinberg A G.
Pedigree
of a family with hereditary chronic relapsing pancreatitis.
Gastroenterology.
1952;
21
54-63
- 9
Férec C, Raguénès O, Salomon R. et al .
Mutations in the cationic trypsinogen gene
and evidence for genetic heterogeneity in hereditary pancreatitis.
J
Med Genet.
1999;
36
228-232
- 10
Gorry M C, Gabbaizedeh D, Furey W. et al .
Mutations in the cationic trypsinogen gene
are associated with recurrent acute and chronic pancreatitis.
Gastroenterology.
1997;
113
1063-1068
- 11
Guy O, Lombardo D, Bartelt D C, Amic J, Figarella C.
Two human trypsinogens:
purification, molecular properties and N-terminal sequences.
Biochemistry.
1978;
17
1669-1675
- 12
Haber P, Wilson J, Apte M. et al .
Individual
susceptibility to alcoholic pancreatitis: still an enigma.
J
Lab Clin Med.
1995;
125
305-312
- 13
Horii A, Kobayashi T, Tomita N. et al .
Primary
structure of human pancreatic secretory trypsin inhibitor (PSTI)
gene.
Biochem Biophys Res Commun.
1987;
149
635-641
- 14
Kazal L A, Spicer D S, Brahinsky R A.
Isolation
of a crystalline trypsin inhibitor-anticoagulant protein from the
pancreas.
J Am Chem Soc.
1948;
70
304-340
- 15
Keim V, Hoffmeister A, Teich N. et al .
The pancreatitis-associated protein
in hereditary and chronic alcoholic pancreatitis.
Pancreas.
1999;
19
248-254
- 16
Kerem B S, Rommens J M, Buchanan J A. et al .
Identification of the cystic fibrosis gene:
genetic analysis.
Science.
1989;
245
1073-1080
- 17
Kimura S, Okabayashi Y, Inushima K, Yutsudo Y, Kasuga M.
Polymorphism
of cystic fibrosis gene in Japanese patients with chronic pancreatitis.
Dig
Dis Sci.
2000;
45
2007-2012
- 18
Laskowski M, Wu F C.
Temporary inhibition
of trypsin.
J Biol Chem.
1953;
204
797-805
- 19
Le B odic
L, Bignon J D, Raguénès O. et al .
The hereditary pancreatitis gene maps to
long arm of chromosome 7.
Hum Mol Genet.
1996;
5
549-554
- 20
Lerch M M, Gorelick F S.
Early trypsinogen
activation in acute pancreatitis.
Gastroenterol Clin North
Am.
2000;
84
549-563
- 21
Lerch M M, Ellis I, Whitcomb D C, Keim V. et al .
Maternal
inheritance pattern of hereditary pancreatitis in patients with
pancreatic carcinoma.
J Natl Cancer Inst.
1999;
91
723-724
- 22
Lowenfels A B, Maisonneuve P, Cavallini G. et al .
Pancreatitis and the risk of pancreatic
cancer. International Hereditary Pancreatitis Study Group.
N
Engl J Med.
1993;
328
1433-1437
- 23
Lowenfels A B, Maisonneuve P.
Risk factors for
cancer in hereditary pancreatitis.
Med Clin North Am.
2000;
84
5565-5573
- 24
Malats N, Casals T, Porta M, Guarner L, Estivill X, Real F X.
Cystic
fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T
allele in patients with chronic pancreatitis and exocrine pancreatic
cancer.
Gut.
2001;
48
70-74
- 25
Nishimori I, Kamakura M, Fujikawa-Adachi K. et al .
Mutations in exons 2 and 3 of the cationic
trypsinogen gene in Japanese families with hereditary pancreatitis.
Gut.
1999;
44
259-263
- 26
Norton I, Apte M, Dixson H. et
al .
Cystic fibrosis genotypes and alcoholic pancreatitis.
J
Gastroenterol Hepatol.
1998;
13
496-499
- 27
Ockenga J, Stuhrmann M, Ballmann M. et al .
Mutations of the cystic fibrosis gene,
but not cationic trypsinogen gene, are associated with recurrent
or chronic idiopathic pancreatitis.
Am J Gastroenterol.
2000;
95
2061-2067
- 28 Online Mendelian Inheritance
in Man (OMIM). http:// www.ncbi.nlm.nih.gov
- 29 Owyang C, Levitt M. Chronic pancreatitis. Philadelphia:
Lippincott In: Yamada T, ed. Textbook of Gastroenterology.
2nd ed 1991: 1874-1893
- 30
Pandya A, Blanton S H, Landa B. et al .
Linkage studies in a large kindred with
hereditary pancreatitis confirms mapping of the gene to a 16-cM
region on 7q.
Genomics.
1996;
38
227-230
- 31
Perrault J.
Hereditary
pancreatitis.
Gastroenterol Clin North Am.
1994;
23
743-752
- 32
Pfützer R H, Whitcomb D C.
Trypsinogen
mutations in chronic pancreatitis (letter).
Gastroenterology.
1999;
117
1507-1508
- 33
Pfützer R H, Barmada N M, Brunskill A PJ. et al .
SPINK1/PSTI polymorphisms act
as disease modifiers in familial and idiopathic chronic pancreatitis.
Gastroenterology.
2000;
119
615-623
- 34
Ravnik-Glavac M, Glavac D, di Sant’Agnese P, Chernick M, Dean M.
Cystic
fibrosis gene mutations detected in hereditary pancreatitis.
Pflügers
Arch.
1996;
431
R191-R192
(Suppl)
- 35
Rinderknecht H.
Activation
of pancreatic zymogens. Normal activation, premature intrapancreatic
activation, protective mechanisms against inappropriate activation.
Dig
Dis Sci.
1986;
31
314-321
- 36
Riordan J R, Rommens J M, Kerem B. et al .
Identification of the cystic fibrosis gene.
Science.
1989;
245
1066-1073
- 37
Sahin-Tóth M, Gráf L, Tóth M.
Trypsinogen
stabilization by mutation arg117-to-his: a unifying pathomechanism
for hereditary pancreatitis?.
Biochem Biophys Res Commun.
1999;
264
505-508
- 38
Sahin-Tóth M.
Hereditary
pancreatitis-associated mutation Asn21 Ile stabilizes rat trypsinogen
in vitro.
J Biol Chem.
1999;
274
29 699-29 704
- 39
Sahin-Tóth M.
Human
cationic trypsinogen. Role of Asn-21 in zymogen activation and implications
in hereditary pancreatitis.
J Biol Chem.
2000;
275
22 750-22 755
- 40
Sahin-Tóth M, Tóth M.
Gain-of-function
mutations associated with hereditary pancreatitis enhance autoactivation
of human cationic trypsinogen.
Biochem Biophys Res Commun.
2000;
278
286-289
- 41
Sharer N, Schwarz M, Malone G. et al .
Mutations of the cystic fibrosis gene in
patients with chronic pancreatitis.
New Engl J Med.
1998;
339
645-652
- 42
Shwachman H, Lebenthal E, Khaw W.
Recurrent
acute pancreatitis in patients with cystic fibrosis with normal
pancreatic enzymes.
Pediatrics.
1975;
55
86-94
- 43
Simon P, Zimmer K P, Domschke W, Lerch M M.
Cationic
trypsinogen mutations in patients with idiopathic pancreatitis.
Pancreas.
1999;
19
438
- 44
Simon P, Zimmer K P, Domschke W, Lerch M M.
Etiological
risk factors for familial pancreatitis.
Gastroenterology.
2000;
118
A423
- 45
Simon P, Weiss F U, Domschke W, Lerch M M.
Mutationen
im pankreatischen Trypsininhibitor (SPINK-1) bei Patienten mit idiopathischer
chronischer Pankreatitis.
Med Klin.
2001;
96
188
- 46
Teich N, Mössner J, Keim V.
Screening for mutations
of the cationic trypsinogen gene: are they of relevance in chronic
alcoholic pancreatitis?.
Gut.
1999;
44
413-416
- 47
Teich N, Mössner J, Keim V.
Mutations of the cationic
trypsinogen in hereditary pancreatitis.
Hum Mut.
1998;
12
39-43
- 48
Teich N, Ockenga J, Hoffmeister A, Manns M, Mössner J, Keim V.
Chronic
pancreatitis associated with an activation peptide mutation that
facilitates trypsin activation.
Gastroenterology.
2000;
119
461-465
- 49
Welsh M, Smith A.
Molecular
mechanisms of CFTR chloride channel dysfunction in cystic fibrosis.
Cell.
1993;
73
1251-1254
- 50
Whitcomb D C, Gorry M C, Preston R A. et al .
Hereditary pancreatitis is caused by a
mutation in the cationic trypsinogen gene.
Nature Genet.
1996;
14
141-145
- 51
Whitcomb D C, Preston R A, Aston C E. et al .
A gene for hereditary pancreatitis maps
to chromosome 7q35.
Gastroenterology.
1996;
110
1975-1980
- 52
Witt H, Luck W, Becker M.
A signal peptide cleavage
site mutation in the cationic trypsinogen gene is strongly associated
with chronic pancreatitis.
Gastroenterology.
1999;
117
7-10
- 53
Witt H, Luck W, Becker M. et al .
Mutation
in the SPINK1 trypsin inhibitor gene, alcohol use and chronic pancreatitis.
JAMA.
2001;
285
2716-2717
- 54
Witt H, Luck W, Hennies H C. et al .
Mutations
in the gene encoding the serine protease inhibitor, Kazal type
1 are associated with chronic pancreatitis.
Nature Genet.
2000;
25
213-216
- 55
Witt H, Hennies H C, Becker M.
SPINK1 mutations in chronic
pancreatitis (letter).
Gastroenterology.
2001;
120
1060-1061
- 56
Várallyay É, Pál G, Patthy A, Szilágyi L, Gráf L.
Two
mutations in the rat trypsin confer resistance against autolysis.
Biochem
Biophys Res Commun.
1998;
243
56-60
1 Herrn Prof. Dr. Dr. h.c. Wolfgang Gerok
zum 75. Geburtstag gewidmet
Korrespondenz
Prof. Dr. Markus M. Lerch
Medizinische Klinik B der Westfälischen
Wilhelms-Universität Münster
Albert-Schweitzer-Straße 33
48129 Münster
Email: markus.lerch@uni-muenster.de
